Inventor · disambiguated record
John A. Mclane
Also filed as: MCLANE JOHN A · MCLANE JOHN ARTHUR
9 granted patents·4 pending applications·184 citations·filing 1988–2022
87Inventor score
Top patents by PatentIndex Score
13 records- 0193US5021451AMethod for inhibiting hyperproliferative diseasesHOFFMANN LA ROCHE·Filed 1988·Granted Jun 4, 1991·86 cites·19 claims
- 0287US5428029AVitamin D3 fluorinated analogsHOFFMANN LA ROCHE·Filed 1993·Granted Jun 27, 1995·73 cites·14 claims
- 0364US2022313772A1Method of Treating a Child with Central Precocious Puberty using an Extended Release CompositionTOLMAR INTERNATIONAL LTD·Filed 2022·Application pending·0 cites
- 0459US12453754B2Leuprolide acetate compositions and methods of using the same to treat breast cancerTOLMAR INTERNATIONAL LTD·Filed 2020·Granted Oct 28, 2025·0 cites·20 claims
- 0557US5342833AVitamin D3 analogsHOFFMANN LA ROCHE·Filed 1993·Granted Aug 30, 1994·9 cites·6 claims
- 0653US2009215892A1Octanol Formulations and Methods of Treatment Using the SameNAHAB FATTA B·Filed 2006·Application pending·0 cites
- 0752US5747478AVitamin D3 analogs for the treatment of psoriasis and sebaceous gland diseasesHOFFMANN LA ROCHE·Filed 1994·Granted May 5, 1998·7 cites·9 claims
- 0852US2020330547A1Method of Treating a Child with Central Precocious Puberty using an Extended Release CompositionTOLMAR INTERNATIONAL LTD·Filed 2019·Application pending·0 cites
- 0950US2011112010A1Octanoic acid formulations and methods of treatment using the sameUS GOV HEALTH & HUMAN SERV·Filed 2009·Application pending·0 cites
- 1043US5401733AStable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferolHOFFMANN LA ROCHE·Filed 1993·Granted Mar 28, 1995·6 cites·18 claims
- 1140US5393900ASteroid intermediates for the formation of vitamin D3 analoguesHOFFMANN LA ROCHE·Filed 1994·Granted Feb 28, 1995·2 cites·10 claims
- 1233US5073568AAntipsoriatic agentsHOFFMANN LA ROCHE·Filed 1988·Granted Dec 17, 1991·1 cites·10 claims
- 1328US5200549AAntipsoriatic agentsHOFFMANN LA ROCHE·Filed 1991·Granted Apr 6, 1993·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →